Focusing specifically on the challenges drug developers face in the development of bispecific therapeutics, the 9th Annual World Bispecific Summit is your opportunity to fast-track your development efforts in this space.
This year Novartis, Xencor, MedImmune, Regeneron and Pfizer will be contributing fresh insights, lessons learned and clinical updates specifically geared towards enabling you to realize the potential of your bispecific candidates.
“The best conference in the bispecific field.”
“Highly interactive conference with excellent presentations and exciting data.”
Download the full program to find out what will be discussed, meet our expert speaker faculty, networking opportunities, fees and discounts.